A
AMLo Biosciences
0 followers
Formed in late 2017, AMLo Biosciences is dedicated to providing a prognostic test for early AJCC Stage I and Stage II melanoma to better identify patients’ true risk of disease progression.
Org chart
Marie Labus
Chief Executive Officer
Marie Labus
Collapse
Penny Lovat
Chief Scientific Officer
Akhtar Husain
Chief Medical Officer
Jane Meaney
Chief Marketing Officer
Sarah Cockman
Quality Assurance & Regulatory Affairs Manager
Catherine Graham
Project Manager
Board & advisors
Sandy Primrose
Chair
David MacDonald
Board Member